Literature DB >> 30793759

Successful treatment of refractory mechanic's hands with ustekinumab in a patient with the antisynthetase syndrome.

Iago Pinal-Fernandez1,2, Christopher T Kroodsma3, Andrew L Mammen1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30793759      PMCID: PMC6821353          DOI: 10.1093/rheumatology/kez020

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  A histopathologic study of mechanic's hands associated with dermatomyositis: a report of five cases.

Authors:  Sumiyuki Mii; Ritsuko Kobayashi; Toshiaki Nakano; Harumi Harada; Masato Okada; Yukio Matsui; Takao Fujii; Hikaru Eto
Journal:  Int J Dermatol       Date:  2009-11       Impact factor: 2.736

Review 2.  Psoriasis.

Authors:  Frank O Nestle; Daniel H Kaplan; Jonathan Barker
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

3.  A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.

Authors:  Iago Pinal-Fernandez; Maria Casal-Dominguez; Julio A Huapaya; Jemima Albayda; Julie J Paik; Cheilonda Johnson; Leann Silhan; Lisa Christopher-Stine; Andrew L Mammen; Sonye K Danoff
Journal:  Rheumatology (Oxford)       Date:  2017-06-01       Impact factor: 7.580

4.  Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.

Authors:  Brian G Feagan; William J Sandborn; Christopher Gasink; Douglas Jacobstein; Yinghua Lang; Joshua R Friedman; Marion A Blank; Jewel Johanns; Long-Long Gao; Ye Miao; Omoniyi J Adedokun; Bruce E Sands; Stephen B Hanauer; Severine Vermeire; Stephan Targan; Subrata Ghosh; Willem J de Villiers; Jean-Frédéric Colombel; Zsolt Tulassay; Ursula Seidler; Bruce A Salzberg; Pierre Desreumaux; Scott D Lee; Edward V Loftus; Levinus A Dieleman; Seymour Katz; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2016-11-17       Impact factor: 91.245

5.  Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up.

Authors:  K A Papp; C E M Griffiths; K Gordon; M Lebwohl; P O Szapary; Y Wasfi; D Chan; M-C Hsu; V Ho; P D Ghislain; B Strober; K Reich
Journal:  Br J Dermatol       Date:  2013-04       Impact factor: 9.302

  5 in total
  4 in total

Review 1.  A glance into the future of myositis therapy.

Authors:  Ilaria Chiapparoli; Claudio Galluzzo; Carlo Salvarani; Nicolò Pipitone
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-24       Impact factor: 3.625

Review 2.  Psoriasis and Connective Tissue Diseases.

Authors:  Toshiyuki Yamamoto
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

3.  Mechanic's hand; is it a prodromic sign of disease relapse of anti-synthetase syndrome; a case report.

Authors:  C T Rosa; A S Thilakarathne; L A Senevirathne; A Wijeyeratna; D Munidasa
Journal:  BMC Rheumatol       Date:  2021-07-26

Review 4.  Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review.

Authors:  Jo L W Lambert; Sofie De Schepper; Reinhart Speeckaert
Journal:  J Clin Med       Date:  2021-03-03       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.